After four weeks of the combination, scans showed no remaining evidence of tumors from his melanoma. That was nine years ago, and there has been no evidence of cancer since. (He continues to take low, maintenance doses of both medicines.)
Patients with other cancers began requesting the new drug combination soon after Cantrell's recovery. Continuing to see its potential in those patients, Cantrell left his surgical practice to devote his career to developing the treatment.
Patients from 28 states and four countries have now used the new combination with promising results. They are being treated for extremely aggressive cancers, such as pancreatic, colon, renal, some sarcomas, mesothelioma, melanoma and others. Eventually Cantrell hopes to implement formal clinical trials, but helping individuals remains his priority.
The treatment's medicines have the advantage of being safe and well tolerated. Most patients never experience effects commonly affiliated with chemotherapy or radiation (nausea, vomiting, hair loss, bone marrow suppression or immune system suppression).
NeoPlas Innovation's web site, www.neoplas.org, provides detailed information about the treatment. Additionally, the clinic can be reached at (615) 371-8100.
For information, contact:
Dawn Bramblett
731-989-8019 or 731-608-7650
# # #
| Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved |